Vemurafenib

Curated

← predicts response to

BRAF V600ESNV

sensitivity

Curated

Hairy Cell Leukemia,Langerhans Cell Sarcoma,Low Grade Glioma+6

← predicts response to

BRAF V600ESNV

17 source records aggregated

sensitivity

Curated

Cholangiocarcinoma,Langerhans Cell Histiocytosis,Lung Non-Small Cell Carcinoma+2

← predicts response to

BRAF V600

6 source records aggregated

sensitivity

Curated

← predicts response to

BRAF V600ESNV

3 source records aggregated

resistance

Curated

← predicts response to

BRAF V600KSNV

3 source records aggregated

sensitivity

Curated

← predicts response to

KRAS Mutationother

resistance

Curated

← predicts response to

NRAS Mutationother

resistance

Curated

← predicts response to

BRAF V600KSNV

resistance

Curated

← predicts response to

BRAF Amplificationamplification

resistance

Curated

← predicts response to

BRAF K601ESNV

sensitivity

Curated

← predicts response to

BRAF intron 9 rearrangementstructural

resistance

Curated

← predicts response to

BRAF intron 10 rearrangementstructural

resistance

Curated

← predicts response to

BRAF L505HSNV

resistance

Curated

← predicts response to

BRAF V600

resistance

Curated

Vemurafenib targets …TARGETS1 of 1
→ targets	BRAF	—	INHIBITOR	—	1	Curated	chembl	graph →

Vemurafenib targets …TARGETS1 of 1

→ targets

BRAF

—

INHIBITOR

—

Curated

Vemurafenib investigated for …INVESTIGATED_FOR46 of 46show fewer
→ investigated for	Melanomacancer_family 2 source records aggregated	supports	A	Melanoma	2	Curated	civic	graph →
→ investigated for	Cutaneous Melanomacancer	supports	A	Cutaneous Melanoma	1	Curated	civic	graph →
→ investigated for	Melanomacancer_family 18 source records aggregated	supports	B	Melanoma	18	Curated	civic	graph →
→ investigated for	Malignant Colorectal Neoplasmsubtype 4 source records aggregated	supports	B	Malignant Colorectal Neoplasm	4	Curated	civic	graph →
→ investigated for	Thyroid Gland Papillary Carcinomasubtype 2 source records aggregated	supports	B	Thyroid Gland Papillary Carcinoma	2	Curated	civic	graph →
→ investigated for	Lung Non-Small Cell Carcinomasubtype 2 source records aggregated	supports	B	Lung Non-Small Cell Carcinoma	2	Curated	civic	graph →
→ investigated for	Hairy Cell Leukemiahematologic_malignancy	supports	B	Hairy Cell Leukemia	1	Curated	civic	graph →
→ investigated for	Low Grade Gliomasubtype	supports	B	Low Grade Glioma	1	Curated	civic	graph →
→ investigated for	Thyroid Gland Anaplastic Carcinomasubtype	supports	B	Thyroid Gland Anaplastic Carcinoma	1	Curated	civic	graph →
→ investigated for	Malignant Ovarian Neoplasmcancer	supports	B	Malignant Ovarian Neoplasm	1	Curated	civic	graph →
→ investigated for	Langerhans Cell Histiocytosishematologic_malignancy	supports	B	Langerhans Cell Histiocytosis	1	Curated	civic	graph →
→ investigated for	Langerhans Cell Sarcomahematologic_malignancy	supports	B	Langerhans Cell Sarcoma	1	Curated	civic	graph →
→ investigated for	Cholangiocarcinomasubtype	supports	B	Cholangiocarcinoma	1	Curated	civic	graph →
→ investigated for	Cutaneous Melanomacancer	supports	B	Cutaneous Melanoma	1	Curated	civic	graph →
→ investigated for	Neoplasmcancer_family	unknown	4	Neoplasm	1	Curated	chembl	graph →
→ investigated for	Melanomacancer_family	unknown	4	Melanoma	1	Curated	chembl	graph →
→ investigated for	Malignant Colorectal Neoplasmsubtype 5 source records aggregated	supports	C	Malignant Colorectal Neoplasm	5	Curated	civic	graph →
→ investigated for	Melanomacancer_family 4 source records aggregated	supports	C	Melanoma	4	Curated	civic	graph →
→ investigated for	Multiple Myelomahematologic_malignancy 2 source records aggregated	supports	C	Multiple Myeloma	2	Curated	civic	graph →
→ investigated for	Cutaneous Melanomacancer 2 source records aggregated	supports	C	Cutaneous Melanoma	2	Curated	civic	graph →
→ investigated for	Skin Squamous Cell Carcinomasubtype	supports	C	Skin Squamous Cell Carcinoma	1	Curated	civic	graph →
→ investigated for	Malignant Pancreatic Neoplasmcancer	supports	C	Malignant Pancreatic Neoplasm	1	Curated	civic	graph →
→ investigated for	Hairy Cell Leukemiahematologic_malignancy	supports	C	Hairy Cell Leukemia	1	Curated	civic	graph →
→ investigated for	Laryngeal Squamous Cell Carcinomasubtype	supports	C	Laryngeal Squamous Cell Carcinoma	1	Curated	civic	graph →
→ investigated for	Thyroid Gland Anaplastic Carcinomasubtype	supports	C	Thyroid Gland Anaplastic Carcinoma	1	Curated	civic	graph →
→ investigated for	Cholangiocarcinomasubtype	supports	C	Cholangiocarcinoma	1	Curated	civic	graph →
→ investigated for	Ovarian Serous Adenocarcinomasubtype	supports	C	Ovarian Serous Adenocarcinoma	1	Curated	civic	graph →
→ investigated for	Childhood Pilocytic Astrocytomasubtype	supports	C	Childhood Pilocytic Astrocytoma	1	Curated	civic	graph →
→ investigated for	Digestive System Neuroendocrine Tumorsubtype	supports	C	Digestive System Neuroendocrine Tumor	1	Curated	civic	graph →
→ investigated for	Thyroid Gland Papillary Carcinomasubtype	supports	C	Thyroid Gland Papillary Carcinoma	1	Curated	civic	graph →
→ investigated for	Melanomacancer_family 26 source records aggregated	supports	D	Melanoma	26	Curated	civic	graph →
→ investigated for	Cutaneous Melanomacancer 7 source records aggregated	supports	D	Cutaneous Melanoma	7	Curated	civic	graph →
→ investigated for	Malignant Colorectal Neoplasmsubtype 7 source records aggregated	supports	D	Malignant Colorectal Neoplasm	7	Curated	civic	graph →
→ investigated for	Childhood Pilocytic Astrocytomasubtype	supports	D	Childhood Pilocytic Astrocytoma	1	Curated	civic	graph →
→ investigated for	Hematopoietic and Lymphoid Cell Neoplasmcancer_family	unknown	2	Hematopoietic and Lymphoid Cell Neoplasm	1	Curated	chembl	graph →
→ investigated for	Pancreatic Neoplasmsubtype	unknown	2	Pancreatic Neoplasm	1	Curated	chembl	graph →
→ investigated for	Thyroid Gland Neoplasmsubtype	unknown	2	Thyroid Gland Neoplasm	1	Curated	chembl	graph →
→ investigated for	Colorectal Neoplasmsubtype	unknown	2	Colorectal Neoplasm	1	Curated	chembl	graph →
→ investigated for	Hairy Cell Leukemiahematologic_malignancy	unknown	2	Hairy Cell Leukemia	1	Curated	chembl	graph →
→ investigated for	Craniopharyngiomacancer	unknown	2	Craniopharyngioma	1	Curated	chembl	graph →
→ investigated for	Acute Myeloid Leukemiahematologic_malignancy	unknown	2	Acute Myeloid Leukemia	1	Curated	chembl	graph →
→ investigated for	Lung Non-Small Cell Carcinomasubtype	unknown	2	Lung Non-Small Cell Carcinoma	1	Curated	chembl	graph →
→ investigated for	Multiple Myelomahematologic_malignancy	unknown	2	Multiple Myeloma	1	Curated	chembl	graph →
→ investigated for	Skin Neoplasmcancer_family	unknown	1	Skin Neoplasm	1	Curated	chembl	graph →
→ investigated for	Lymphomacancer_family	unknown	1	Lymphoma	1	Curated	chembl	graph →
→ investigated for	Paragangliomasubtype	unknown	0.5	Paraganglioma	1	Curated	chembl	graph →

Vemurafenib investigated for …INVESTIGATED_FOR46 of 46show fewer

→ investigated for

Melanomacancer_family

2 source records aggregated

supports

Curated

→ investigated for

supports

Curated

→ investigated for

Melanomacancer_family

18 source records aggregated

supports

Curated

→ investigated for

4 source records aggregated

supports

Curated

Thyroid Gland Papillary Carcinoma

→ investigated for

Thyroid Gland Papillary Carcinomasubtype

2 source records aggregated

supports

Curated

→ investigated for

Lung Non-Small Cell Carcinomasubtype

2 source records aggregated

supports

Curated

→ investigated for

Hairy Cell Leukemiahematologic_malignancy

supports

Curated

→ investigated for

Low Grade Gliomasubtype

supports

Low Grade Glioma

Curated

Thyroid Gland Anaplastic Carcinoma

→ investigated for

Thyroid Gland Anaplastic Carcinomasubtype

supports

Curated

Malignant Ovarian Neoplasm

→ investigated for

Malignant Ovarian Neoplasmcancer

supports

Curated

Langerhans Cell Histiocytosis

→ investigated for

Langerhans Cell Histiocytosishematologic_malignancy

supports

Curated

→ investigated for

Langerhans Cell Sarcomahematologic_malignancy

supports

Langerhans Cell Sarcoma

Curated

→ investigated for

Cholangiocarcinomasubtype

supports

Cholangiocarcinoma

Curated

→ investigated for

supports

Curated

→ investigated for

Neoplasmcancer_family

unknown

Neoplasm

Curated

→ investigated for

Melanomacancer_family

unknown

Curated

→ investigated for

5 source records aggregated

supports

Curated

→ investigated for

Melanomacancer_family

4 source records aggregated

supports

Curated

→ investigated for

Multiple Myelomahematologic_malignancy

2 source records aggregated

supports

Multiple Myeloma

Curated

→ investigated for

2 source records aggregated

supports

Curated

Skin Squamous Cell Carcinoma

→ investigated for

Skin Squamous Cell Carcinomasubtype

supports

Curated

Malignant Pancreatic Neoplasm

→ investigated for

Malignant Pancreatic Neoplasmcancer

supports

Curated

→ investigated for

Hairy Cell Leukemiahematologic_malignancy

supports

Curated

Laryngeal Squamous Cell Carcinoma

→ investigated for

Laryngeal Squamous Cell Carcinomasubtype

supports

Curated

Thyroid Gland Anaplastic Carcinoma

→ investigated for

Thyroid Gland Anaplastic Carcinomasubtype

supports

Curated

→ investigated for

Cholangiocarcinomasubtype

supports

Cholangiocarcinoma

Curated

Ovarian Serous Adenocarcinoma

→ investigated for

Ovarian Serous Adenocarcinomasubtype

supports

Curated

Childhood Pilocytic Astrocytoma

→ investigated for

Childhood Pilocytic Astrocytomasubtype

supports

Curated

Digestive System Neuroendocrine Tumor

→ investigated for

Digestive System Neuroendocrine Tumorsubtype

supports

Curated

Thyroid Gland Papillary Carcinoma

→ investigated for

Thyroid Gland Papillary Carcinomasubtype

supports

Curated

→ investigated for

Melanomacancer_family

26 source records aggregated

supports

Curated

→ investigated for

7 source records aggregated

supports

Curated

→ investigated for

7 source records aggregated

supports

Curated

Childhood Pilocytic Astrocytoma

→ investigated for

Childhood Pilocytic Astrocytomasubtype

supports

Curated

Hematopoietic and Lymphoid Cell Neoplasm

→ investigated for

Hematopoietic and Lymphoid Cell Neoplasmcancer_family

unknown

Curated

→ investigated for

Pancreatic Neoplasmsubtype

unknown

Pancreatic Neoplasm

Curated

→ investigated for

Thyroid Gland Neoplasmsubtype

unknown

Thyroid Gland Neoplasm

Curated

→ investigated for

Colorectal Neoplasmsubtype

unknown

Colorectal Neoplasm

Curated

→ investigated for

Hairy Cell Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

Craniopharyngiomacancer

unknown

Craniopharyngioma

Curated

→ investigated for

Acute Myeloid Leukemiahematologic_malignancy

unknown

Acute Myeloid Leukemia

Curated

→ investigated for

Lung Non-Small Cell Carcinomasubtype

unknown

Curated

→ investigated for

Multiple Myelomahematologic_malignancy

unknown

Multiple Myeloma

Curated

→ investigated for

Skin Neoplasmcancer_family

unknown

Skin Neoplasm

Curated

→ investigated for

Lymphomacancer_family

unknown

Lymphoma

Curated

→ investigated for

Paragangliomasubtype

unknown

0.5

Paraganglioma

Curated

Vemurafenib investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 86show all (up to 200)
→ investigated in trials for	Melanomacancer_family 64 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Melanoma	64	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Neoplasm 11 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Solid Neoplasm 10 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Solid Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Neoplasmcancer_family 6 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Lung Non-Small Cell Carcinomasubtype 5 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Lung Non-Small Cell Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Solid Neoplasm 5 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Solid Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Hematopoietic and Lymphoid Cell Neoplasmcancer_family 4 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Hematopoietic and Lymphoid Cell Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Colorectal Neoplasmsubtype 4 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Colorectal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Hairy Cell Leukemiahematologic_malignancy 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Hairy Cell Leukemia	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Thyroid Gland Neoplasm 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Thyroid Gland Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Multiple Myelomahematologic_malignancy 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Multiple Myeloma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Non-Hodgkin Lymphoma 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Non-Hodgkin Lymphoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Rare Neoplasm 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Rare Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Thyroid Gland Carcinoma 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Thyroid Gland Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Thyroid Gland Papillary Carcinomasubtype 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Thyroid Gland Papillary Carcinoma	3	Observed	clinicaltrials	graph →

Vemurafenib investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 86show all (up to 200)

→ investigated in trials for

Melanomacancer_family

64 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

→ investigated in trials for

Malignant Neoplasm

11 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Malignant Neoplasm

Observed

→ investigated in trials for

Solid Neoplasm

10 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Solid Neoplasm

Observed

→ investigated in trials for

Neoplasmcancer_family

6 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Neoplasm

Observed

→ investigated in trials for

Lung Non-Small Cell Carcinomasubtype

5 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

→ investigated in trials for

Malignant Solid Neoplasm

5 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Malignant Solid Neoplasm

Observed

Hematopoietic and Lymphoid Cell Neoplasm

→ investigated in trials for

Hematopoietic and Lymphoid Cell Neoplasmcancer_family

4 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

→ investigated in trials for

4 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

→ investigated in trials for

Hairy Cell Leukemiahematologic_malignancy

3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

Malignant Thyroid Gland Neoplasm

→ investigated in trials for

3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Malignant Thyroid Gland Neoplasm

Observed

→ investigated in trials for

Multiple Myelomahematologic_malignancy

3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Multiple Myeloma

Observed

→ investigated in trials for

Non-Hodgkin Lymphoma

3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Non-Hodgkin Lymphoma

Observed

→ investigated in trials for

Rare Neoplasm

3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Rare Neoplasm

Observed

→ investigated in trials for

Thyroid Gland Carcinoma

3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Thyroid Gland Carcinoma

Observed

Thyroid Gland Papillary Carcinoma

→ investigated in trials for

Thyroid Gland Papillary Carcinomasubtype

3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

Malignant Thyroid Gland Neoplasm

Vemurafenib studied in …STUDIED_INderived10 of 119show all (up to 200)
→ studied in	NCT01709292Phase 2 · active not recruiting Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer · 119 trials list this drug (19 active)	—	—	Malignant Thyroid Gland Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04302025Phase 2 · recruiting A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC) · 119 trials list this drug (19 active)	—	—	Lung Non-Small Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06561360Phase 2 · recruiting A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL) · 119 trials list this drug (19 active)	—	—	Hairy Cell Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT03178552Phase 2/Phase 3 · active not recruiting A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) · 119 trials list this drug (19 active)	—	—	Lung Non-Small Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03410875Phase 2 · active not recruiting A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia · 119 trials list this drug (19 active)	—	—	Leukemia,Hairy Cell Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · 119 trials list this drug (19 active)	—	—	Hepatoblastoma,Malignant Germ Cell Tumor,Malignant Solid Neoplasm+2	1	Observed	clinicaltrials	graph →
→ studied in	NCT03181100Phase 2 · active not recruiting Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer · 119 trials list this drug (19 active)	—	—	Thyroid Gland Anaplastic Carcinoma,Thyroid Gland Carcinoma,Poorly Differentiated Thyroid Gland Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03768063Phase 3 · active not recruiting A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study · 119 trials list this drug (19 active)	—	—	Malignant Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT05525858recruiting KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II · 119 trials list this drug (19 active)	—	—	Malignant Neoplasm,Solid Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04722575Phase 2 · active not recruiting Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma · 119 trials list this drug (19 active)	—	—	Melanoma	1	Observed	clinicaltrials	graph →

Vemurafenib studied in …STUDIED_INderived10 of 119show all (up to 200)

→ studied in

NCT01709292Phase 2 · active not recruiting

Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer · 119 trials list this drug (19 active)

—

Observed

→ studied in

NCT04302025Phase 2 · recruiting

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC) · 119 trials list this drug (19 active)

—

Observed

→ studied in

NCT06561360Phase 2 · recruiting

A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL) · 119 trials list this drug (19 active)

—

Observed

→ studied in

NCT03178552Phase 2/Phase 3 · active not recruiting

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) · 119 trials list this drug (19 active)

—

Observed

Leukemia,Hairy Cell Leukemia

→ studied in

NCT03410875Phase 2 · active not recruiting

A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia · 119 trials list this drug (19 active)

—

Observed

Hepatoblastoma,Malignant Germ Cell Tumor,Malignant Solid Neoplasm+2

→ studied in

NCT03155620Phase 2 · active not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · 119 trials list this drug (19 active)

—

Observed

Thyroid Gland Anaplastic Carcinoma,Thyroid Gland Carcinoma,Poorly Differentiated Thyroid Gland Carcinoma

→ studied in

NCT03181100Phase 2 · active not recruiting

Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer · 119 trials list this drug (19 active)

—

Observed

→ studied in

NCT03768063Phase 3 · active not recruiting

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study · 119 trials list this drug (19 active)

—

Malignant Neoplasm

Observed

Malignant Neoplasm,Solid Neoplasm

→ studied in

NCT05525858recruiting

KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II · 119 trials list this drug (19 active)

—

Observed